A partnership strategy
The idea behind Cantargia's business strategy is to develop product candidates on a proprietary basis until an indication of clinical activity has been obtained. The first project to have reached clinical development is CAN04 and the CANFOUR study adds substantial value to future partnering discussions. Cantargia is, however, also open to collaborations at an earlier stage.
Please contact our CEO, Göran Forsberg, for further information or if interested in a collaboration.